Skip to main content
. 2016 Nov 3;10:313. doi: 10.1186/s13256-016-1104-3

Table 1.

Laboratory results of the patient and antibiotic scheme

Hospitalization time Day 35 Day 38 Day 42 Day 45 Day 49 Day 52 Day 56 Day 59 Day 65 Day 68 Day 72
WBC (×106 cell/ml) 25.04 17.5 17.9 18.1 14.5 18.35 11.4 10.0 10.5 6.6 8.56
Neutrophil (%) 94.9 80.9 79.0 80.9 75.9 86.9 79.4 77.9 63.3 69.5 78.7
Procalcitonin (ng/mL) 2.25 0.75 6.95 0.89 0.10 0.1 0.10 0.05 0.06 0.11 0.05
CSF leukocyte (cell/μL) 1800 270 2540 432 70 1395 18 47 57 31 4
CSF neutrophil (%) 95 71 89 24 20 85 71 78 2 22 NA
CSF lymphocyte (%) 5 29 NA 76 80 15 29 22 98 78 NA
CSF protein (g/L) 7 1.99 2.34 2.58 0.94 1.96 1.23 0.74 2.7 0.8 0.67
CSF glucose (mmol/L) 0.1 0.1 0.1 2.0 1.7 1.1 1.6 2.3 1.7 3.4 3
CSF culture Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg
Urea (mmol/L) 5.0 7.1 7.0 5.5 5.4 NA 2.9 6.3 5.6 5.3 7.0
Creatinine (μmol/L) 87 58 55 51 61 NA 58 40 70 49 60
CSF PCR Not indicated Not indicated Not indicated Ab Ab Ab Ab Neg Neg Neg Neg
Antibiotic therapy Mer 1 g/6 hours + Van 1 g/12 hours Mer 1 g/6 hours + Col 1 MIU/8 hours Mer 2 g/8 hours + Col 2 MIU/8 hours

Ab Acinetobacter baumannii, Col colistin, CSF cerebrospinal spinal fluid, Mer meropenem, MIU million international unit, NA not available, Neg negative, PCR polymerase chain reaction, Van vancomycin, WBC white blood cell